Login / Signup

Characterization and Survival Benefit of Drug Approvals for Metastatic Prostate Cancer, 2004 to 2022.

David J BenjaminArash Rezazadeh Kalebasty
Published in: Clinical Medicine Insights. Oncology (2024)
Keyphrases
  • prostate cancer
  • radical prostatectomy
  • squamous cell carcinoma
  • small cell lung cancer
  • free survival
  • adverse drug
  • drug induced
  • emergency department